AbbVie Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI® (Risankizumab) Subcutaneous Induction in Patients with Crohn's Disease

AbbVie (NYSE: ABBV) today announced positive topline results from the Phase 3, randomized, placebo-controlled, double-blind AFFIRM study evaluating the efficacy and safety of risankizumab (SKYRIZI®) ...
Scientific Research Publishing

Chinese Development Finance and MDG Gap Dynamics: Evidence from Child Mortality and Poverty ()

This paper examines whether Chinese development finance is associated with faster progress toward Millennium Development Goal style targets in low- and middle-income countries. We combine AidData’s ...

CHAR Technologies Ltd.: CHAR Technologies Announces Increase to C$ 3.97M and Closing of Book on Previously Announced Private Placement

TORONTO, ON / ACCESS Newswire / March 6, 2026 / CHAR Technologies ("CHAR Tech" or the "Company") (TSXV:YES) is pleased to announce that the Company, in response to investor demand, has increased the s ...
Forbes

First Internet Bank of Indiana Review

Kevin has been writing and creating personal finance and travel content for over six years. He is the founder of the award-winning blog, Family Money Adventure, and host of the Family Money Adventure ...
Goldseiten

Hycroft Files 2025 10-K and Provides Corporate Update

Hycroft Mining Holding Corp. announces 2025 results and filing of its Form 10-K. 2025 Highlights Continued injury free safety record for third consecutive year with 0.00 total recordable injury ...